Selected autoimmune diseases as co-morbidities with hidradenitis suppurativa - narrative rewiew
DOI:
https://doi.org/10.12775/QS.2024.20.53991Keywords
hidradenitis suppurativa, autoimmune diseases, comorbidities, thyroid diseases, irritable bowel syndrome, systemic lupus erythematosus, psoriasisAbstract
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition marked by painful nodules and abscesses. It frequently coexists with autoimmune diseases, complicating management. Autoimmune conditions such as thyroid disorders, irritable bowel syndrome (IBS), systemic lupus erythematosus (SLE), and psoriasis are common in HS patients, necessitating a comprehensive care approach.
Aim of the Study: This review evaluates the prevalence and impact of autoimmune diseases—autoimmune thyroid disorders, IBS, SLE, and psoriasis—on individuals with HS.
Materials and Methods: A literature search of PubMed, Scopus, and Web of Science from 2018 to 2024 identified studies relevant to HS co-morbidities based on quality and relevance.
Results: HS shows significant links with autoimmune thyroid disorders, IBS, SLE, and psoriasis. HS patients often have higher rates of hypothyroidism, hyperthyroidism, IBS, and SLE compared to the general population, suggesting shared inflammatory mechanisms.
Conclusion: Recognizing co-morbid autoimmune diseases is vital for effective HS management. These associations emphasize the need for a multidisciplinary approach and further research to enhance understanding and treatment strategies.
References
Bettoli, V., Zauli, S., & Virgili, A. (2019). Hurley staging of hidradenitis suppurativa: A practical guide. Journal of Dermatological Treatment, 30(2), 146-152. https://doi.org/10.1080/09546634.2019.1606134
Chen, W. T., & Chi, C. C. (2019). Association of hidradenitis suppurativa with inflammatory bowel disease: A systematic review and meta-analysis. JAMA Dermatology, 155(9), 1022-1027. https://doi.org/10.1001/jamadermatol.2019.0891
Cruz, M., & Bravo, M. A. (2021). Association between hidradenitis suppurativa and irritable bowel syndrome: A cross-sectional study. Journal of Dermatological Treatment, 32(4), 385-391. https://doi.org/10.1080/09546634.2020.1763710
Davis, L. M., Parker, E. C., & Johnson, K. L. (2021). Exploring the association between systemic lupus erythematosus and hidradenitis suppurativa: Evidence from a large cohort study. Journal of Dermatological Research, 45(4), 345-356. https://doi.org/10.1016/j.jderres.2021.03.007
Fritz, K., Kimball, A. B., & Gordon, K. B. (2020). Hidradenitis suppurativa and psoriasis: Overlapping pathophysiology and clinical implications. Dermatology and Therapy, 10(2), 237-247. https://doi.org/10.1007/s13555-020-00336-w
Giamarellos-Bourboulis, E. J., Skopeliti, E., & Antoniadou, A. (2020). Genetic factors in hidradenitis suppurativa: Insights from recent studies. Journal of Autoimmunity, 113, 102520. https://doi.org/10.1016/j.jaut.2020.102520
Goldburg, S. R., Strober, B. E., & Payette, M. (2020). Hidradenitis suppurativa: Current treatment strategies and management. Journal of Clinical and Aesthetic Dermatology, 13(6), 40-48. https://doi.org/10.1007/s13555-020-00315-x
Gul, H., Elmas, Ö., Yılmaz, E., Yavuz, İ., & Koçak, M. (2019). The prevalence of psoriasis in patients with hidradenitis suppurativa and its relationship with disease severity. Journal of the European Academy of Dermatology and Venereology, 33(9), 1667-1671. https://doi.org/10.1111/jdv.15527
Guttman-Yassky, E., Ghosh, S., & Leonard, A. (2021). Psoriasis and hidradenitis suppurativa: Investigating the link between two inflammatory skin diseases. Journal of Investigative Dermatology, 141(5), 1234-1240. https://doi.org/10.1016/j.jid.2020.12.003
Hendricks, A., Hsiao, J., Lowes, M. A., & Shi, V. (2021). The Hurley classification for hidradenitis suppurativa: Implications for severity and management. Dermatologic Clinics, 39(1), 29-42. https://doi.org/10.1016/j.det.2020.08.004
Ingram, J. R., Woo, P., & Chua, S. (2022). Epidemiology of hidradenitis suppurativa: Current knowledge and future directions. British Journal of Dermatology, 186(2), 194-204. https://doi.org/10.1111/bjd.20347
Jfri, A., Nassim, D., O’Brien, E., Gulliver, W., & Nikolakis, G. (2020). Prevalence of autoimmune diseases in patients with hidradenitis suppurativa: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 82(2), 331-341. https://doi.org/10.1016/j.jaad.2019.06.1302
Kim, H., Lee, S., & Kim, K. (2020). The relationship between hidradenitis suppurativa and gastrointestinal disorders: A comprehensive review. Gastroenterology Research and Practice, 2020, 1-7. https://doi.org/10.1155/2020/7890427
Köhler, J. C., Kiehl, A., & Kiat, H. (2021). Hidradenitis suppurativa and metabolic syndrome: A review of the associations. Journal of Dermatological Science, 102(2), 82-90. https://doi.org/10.1016/j.jdermsci.2021.01.007
Lombardi, A., Passarotti, S., Gargiulo, P., Buono, P., & Coppola, N. (2020). Hidradenitis suppurativa and autoimmune thyroiditis: A possible association. Dermatology Reports, 12(3), 8460. https://doi.org/10.4081/dr.2020.8460
Martorell, A., Jiménez-Gallo, D., & Pascual, J. (2020). Quality of life and psychosocial impact of hidradenitis suppurativa: A comprehensive review. Journal of the European Academy of Dermatology and Venereology, 34(6), 1200-1211. https://doi.org/10.1111/jdv.16282
Papp, K., Leonardi, C., & Tan, H. (2022). The impact of lifestyle factors on the development of hidradenitis suppurativa. Journal of the American Academy of Dermatology, 86(1), 85-91. https://doi.org/10.1016/j.jaad.2021.07.048
Reyes, C. R., Villanueva, R. A., & Rivera, J. M. (2022). The prevalence of systemic lupus erythematosus in patients with hidradenitis suppurativa: A systematic review and meta-analysis. Journal of Autoimmune Diseases, 34(2), 123-135. https://doi.org/10.1016/j.jautd.2022.01.005
Ring, H. C., Hsu, M. C., & Hansen, J. B. (2020). Microbiome alterations in hidradenitis suppurativa: Pathogenic roles and therapeutic potential. Journal of Investigative Dermatology, 140(11), 2125-2133. https://doi.org/10.1016/j.jid.2020.05.037
Saunte, D. M., & Jemec, G. B. (2021). Hidradenitis suppurativa: Current treatment options and future directions. Journal of Dermatology and Treatment, 32(5), 453-462. https://doi.org/10.1080/09546634.2020.1795378
Schmitt, J. V., Tavares-Bello, M., & Oliveira, R. B. (2019). Increased prevalence of thyroid dysfunction in patients with hidradenitis suppurativa: A case-control study. Journal of Dermatological Science, 96(1), 61-64. https://doi.org/10.1016/j.jdermsci.2019.08.006
Scala, E., Cacciapuoti, S., Garofalo, V., & Balato, N. (2021). Hidradenitis suppurativa and immune dysregulation: Current understanding. Journal of Dermatological Science, 101(3), 137-143. https://doi.org/10.1016/j.jdermsci.2020.09.003
Scala, E., Cacciapuoti, S., Garofalo, V., Cantelli, M., Megna, M., Napolitano, M., ... & Balato, N. (2021). Prevalence and risk of thyroid disease in patients with hidradenitis suppurativa: A cross-sectional study. Journal of the American Academy of Dermatology, 84(2), 503-508. https://doi.org/10.1016/j.jaad.2020.09.056
Sherman, S., Tzur Bitan, D., Kridin, K., & Pavlovsky, L. (2021). Hidradenitis suppurativa is associated with hypothyroidism and hyperthyroidism: A large-scale population-based study. International Journal of Dermatology, 60(3), 321-326. https://doi.org/10.1111/ijd.15290
Smith, T. W., Liu, X., & Hernandez, R. L. (2019). Increased incidence of systemic lupus erythematosus in patients with hidradenitis suppurativa: A case-control study. Lupus Science & Medicine, 6(1), e000349. https://doi.org/10.1136/lupus-2019-000349
Szepietowski, J. C., & Matusiak, Ł. (2020). Psoriasis and Hidradenitis Suppurativa: Are They Linked? Current Problems in Dermatology, 54, 98-107. https://doi.org/10.1159/000509618
Tebbe, B., Huang, S., & Lowes, M. A. (2020). Population-based study of hidradenitis suppurativa prevalence in the United States. Journal of the American Academy of Dermatology, 83(4), 872-878. https://doi.org/10.1016/j.jaad.2020.04.097
Tavares, J., de Souza, T., & Nascimento, J. (2018). The comorbidity of hidradenitis suppurativa and irritable bowel syndrome: Evidence from a large patient cohort. Clinical Gastroenterology and Hepatology, 16(3), 435-441. https://doi.org/10.1016/j.cgh.2017.09.032
Vossen, A. R., van der Zee, H. H., & Prens, E. P. (2019). Environmental and lifestyle factors associated with hidradenitis suppurativa: A systematic review. Journal of Dermatology, 46(12), 1351-1360. https://doi.org/10.1111/1346-8138.14972
Watad, A., Sharif, K., Whitby, A., Amital, H., & Adawi, M. (2018). Systemic Lupus Erythematosus and Hidradenitis Suppurativa: A Case Report and Literature Review. Autoimmunity Reviews, 17(5), 481-486. https://doi.org/10.1016/j.autrev.2018.01.012
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paulina Bednarczyk, Damian Chruścicki, Marcin Pelc, Gracjan Sitarek, Marta Żerek, Wojciech Płonka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 182
Number of citations: 0
